share_log

Unveiling 5 Analyst Insights On IDEAYA Biosciences

Unveiling 5 Analyst Insights On IDEAYA Biosciences

公布关于IDEAYA Biosciences的5种分析见解
Benzinga ·  05/08 13:01
In the preceding three months, 5 analysts have released ratings for IDEAYA Biosciences (NASDAQ:IDYA), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中,有5位分析师发布了IDEAYA Biosciences(纳斯达克股票代码:IDYA)的评级,提出了从看涨到看跌的各种观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级,简要介绍了过去30天中不断变化的情绪,并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $55.4, a high estimate of $60.00, and a low estimate of $52.00. This current average has increased by 24.02% from the previous average price target of $44.67.
分析师分析的12个月目标股价提供了见解,平均目标价为55.4美元,最高估计为60.00美元,低估值为52.00美元。目前的平均价格较之前的平均目标价44.67美元上涨了24.02%。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级:全面细分
The analysis of recent analyst actions sheds light on...
对分析师近期行为的...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发